Manulife (Manufacturers Life Insurance)’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-40,335
| Closed | -$452K | – | 4436 |
|
|
2017
Q3 | $452K | Sell |
40,335
-949
| -2% | -$10.5K | ﹤0.01% | 2342 |
|
|
2017
Q2 | $454K | Buy |
41,284
+1,459
| +4% | +$14.6K | ﹤0.01% | 2368 |
|
|
2017
Q1 | $390K | Buy |
39,825
+4,623
| +13% | +$46.2K | ﹤0.01% | 2366 |
|
|
2016
Q4 | $381K | Buy |
35,202
+938
| +3% | +$9.38K | ﹤0.01% | 2301 |
|
|
2016
Q3 | $351K | Sell |
34,264
-215
| -0.6% | -$2.34K | ﹤0.01% | 2327 |
|
|
2016
Q2 | $450K | Buy |
34,479
+486
| +1% | +$6.37K | ﹤0.01% | 2103 |
|
|
2016
Q1 | $329K | Sell |
33,993
-214
| -0.6% | -$1.9K | ﹤0.01% | 2249 |
|
|
2015
Q4 | $314 | Buy |
34,207
+997
| +3% | +$8.35K | ﹤0.01% | 2327 |
|
|
2015
Q3 | $230 | Buy |
33,210
+549
| +2% | +$4.7K | ﹤0.01% | 2533 |
|
|
2015
Q2 | $321 | Sell |
32,661
-2,728
| -8% | -$24.8K | ﹤0.01% | 2459 |
|
|
2015
Q1 | $313 | Buy |
35,389
+1,450
| +4% | +$11.6K | ﹤0.01% | 2400 |
|
|
2014
Q4 | $298 | Buy |
33,939
+968
| +3% | +$7.83K | ﹤0.01% | 2355 |
|
|
2014
Q3 | $227 | Sell |
32,971
-2,687
| -8% | -$16.1K | ﹤0.01% | 2563 |
|
|
2014
Q2 | $188K | Sell |
35,658
-5,952
| -14% | -$29K | ﹤0.01% | 2761 |
|
|
2014
Q1 | $190 | Sell |
41,610
-3,168
| -7% | -$15.3K | ﹤0.01% | 2761 |
|
|
2013
Q4 | $225 | Buy |
44,778
+181
| +0.4% | +$871 | ﹤0.01% | 2626 |
|
|
2013
Q3 | $226 | Sell |
44,597
-653
| -1% | -$3.64K | ﹤0.01% | 2565 |
|
|
2013
Q2 | $224K | Buy |
+45,250
| New | +$215K | ﹤0.01% | 2483 |
|
Manulife (Manufacturers Life Insurance)'s SCLN Position: Q4 2017 in Review
Manulife (Manufacturers Life Insurance) sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 40,335 shares — an estimated $452K sold.
Manulife (Manufacturers Life Insurance) first reported a position in SCLN in Q2 2013 and held it in 18 quarters. The position peaked at $454K in Q2 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.
- Manulife (Manufacturers Life Insurance) reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 40,335 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $452K.
- Manulife (Manufacturers Life Insurance) first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 18 quarters.
- Manulife (Manufacturers Life Insurance)'s Sciclone Pharmaceuticals Inc position peaked at $454K in Q2 2017.
- 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2017, filed 8 Feb 2018.